![Kevin S. Harris](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin S. Harris
Corporate Officer/Principal chez American Society for Virology
Postes actifs de Kevin S. Harris
Sociétés | Poste | Début | Fin |
---|---|---|---|
American Society for Virology | Corporate Officer/Principal | 17/04/2009 | - |
Historique de carrière de Kevin S. Harris
Anciens postes connus de Kevin S. Harris
Sociétés | Poste | Début | Fin |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Koronis Pharmaceuticals, Inc.
![]() Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 15/04/2009 | - |
Formation de Kevin S. Harris
Stony Brook University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Entreprise privées | 2 |
---|---|
Koronis Pharmaceuticals, Inc.
![]() Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
American Society for Virology |
- Bourse
- Insiders
- Kevin S. Harris
- Expérience